OMNIPAQUE 70 Drug Patent Profile
✉ Email this page to a colleague
When do Omnipaque 70 patents expire, and when can generic versions of Omnipaque 70 launch?
Omnipaque 70 is a drug marketed by Ge Healthcare and is included in one NDA.
The generic ingredient in OMNIPAQUE 70 is iohexol. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the iohexol profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OMNIPAQUE 70?
- What are the global sales for OMNIPAQUE 70?
- What is Average Wholesale Price for OMNIPAQUE 70?
Summary for OMNIPAQUE 70
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 98 |
Clinical Trials: | 25 |
Patent Applications: | 3,513 |
DailyMed Link: | OMNIPAQUE 70 at DailyMed |
Recent Clinical Trials for OMNIPAQUE 70
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal | Phase 4 |
Claire Bourgeois | Phase 4 |
Fédération des médecins résidents du Québec | Phase 4 |
Pharmacology for OMNIPAQUE 70
Drug Class | Radiographic Contrast Agent |
Mechanism of Action | X-Ray Contrast Activity |
US Patents and Regulatory Information for OMNIPAQUE 70
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ge Healthcare | OMNIPAQUE 70 | iohexol | SOLUTION;URETHRAL | 018956-007 | Jun 1, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OMNIPAQUE 70
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ge Healthcare | OMNIPAQUE 70 | iohexol | SOLUTION;URETHRAL | 018956-007 | Jun 1, 1994 | ⤷ Sign Up | ⤷ Sign Up |
Ge Healthcare | OMNIPAQUE 70 | iohexol | SOLUTION;URETHRAL | 018956-007 | Jun 1, 1994 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for OMNIPAQUE 70
See the table below for patents covering OMNIPAQUE 70 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Netherlands | 7905166 | ⤷ Sign Up | |
New Zealand | 190907 | PREPARATION OF X-RAY CONTRAST AGENT BY AUTOCLAVING A META-CARBOXAMIDO-ORTHO-IODO-N-(BETAHYDROXYALKYL)-ANILINE | ⤷ Sign Up |
Japan | S5531068 | MANUFACTURE OF X RAY CONTRAST AGENT INJECTABLE STERILIZED SOLUTION | ⤷ Sign Up |
Spain | 381202 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |